Table 2.
Organism | n | Susceptibility (%) |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMK | AMP | CRO | CAZ | CIP | GEN | TOB | SXT | MEM | FOX | OXA | CLI | ERY | PEN | ||
Enterobacteriaceae (n = 118 isolates) | |||||||||||||||
E. coli | 33 | 88 | 3 | 29 | 38 | 48 | 50 | 71 | 0 | 90 | |||||
Klebsiella spp. | 60 | 81 | 4 | 18 | 18 | 44 | 28 | 37 | 0 | 82 | |||||
Enterobacter spp. | 11 | 86 | 0 | 28 | 71 | 57 | 33 | 40 | 0 | 80 | |||||
Citrobacter spp. | 5 | 75 | 10 | 0 | 50 | 50 | 40 | 0 | 0 | 100 | |||||
Other | 9 | 100 | 0 | 0 | 67 | 67 | 57 | N/A | 20 | 88 | |||||
Pseudomonas spp. and Acinetobacter spp. (n = 40 isolates) | |||||||||||||||
Pseudomonas spp. | 29 | 73 | 46 | 80 | 47 | 50 | N/A | 75 | |||||||
Acinetobacter spp. | 11 | 73 | N/A | 27 | 22 | 50 | 13 | 39 | |||||||
S. aureus (n = 82 isolates) | |||||||||||||||
S. aureus | 82 | 36 | 59 | 62 | 69 | 59 | 13 |
Susceptibility results were available for a total of 240 blood culture isolates from 226 patients. More than one organism was identified in 14 patients and organisms other than the ones listed in the table were identified in 11 patients, but susceptibility results are not presented.
AMK, amikacin; AMP, ampicillin; CRO, ceftriaxone; CAZ, ceftazidime; CIP, ciprofloxacin; GEN, gentamicin; TOB, tobramycin; SXT, trimethoprim/sulfamethoxazole; MEM, meropenem; FOX, cefoxitin; OXA, oxacillin; CLI, clindamycin; ERY, erythromycin; PEN, penicillin; N/A, not applicable.